Deval L Patrick Global Blood Therapeutics, Inc. (GBT) insider trading activity

GBT Quotes by TradingView

Deval L Patrick is Director of Global Blood Therapeutics, Inc.. Currently has a direct ownership of 0 shares of GBT, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2022, when has been sold 9,037 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

DEVAL L PATRICK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2022
SELL
Sale (or disposition) back to the issuer
-
9,037 Reduced 100.0%
0 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
3,600 Added 28.49%
9,037 Common Stock
Jun 17 2021
BUY
Exercise of conversion of derivative security
-
3,037 Added 35.84%
5,437 Common Stock

Also insider at

AMWL
American Well Corp Healthcare
Director
TWLO
TWILIO INC Communication Services
Director
CERE
Cerevel Therapeutics Holdings, Inc. Healthcare
TOST
Toast, Inc. Technology
Director
GRNA
GreenLight Biosciences Holdings, PBC Healthcare
DLP

Deval L Patrick

Director
Cambridge, MA

Track Institutional and Insider Activities on GBT

Follow Global Blood Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells GBT shares.

Notify only if

Insider Trading

Get notified when an Global Blood Therapeutics, Inc. insider buys or sells GBT shares.

Notify only if

News

Receive news related to Global Blood Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on GBT